SCYNEXIS Inc SCYX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:18 PM EDT
1.48quote price arrow up+0.05 (+3.76%)
Volume
158,452
52 week range
1.35 - 3.87
Loading...
  • Open1.42
  • Day High1.52
  • Day Low1.42
  • Prev Close1.43
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap55.015M
  • Shares Out37.21M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.58
  • YTD % Change-34.08

KEY STATS

  • Open1.42
  • Day High1.52
  • Day Low1.42
  • Prev Close1.43
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24
  • Market Cap55.015M
  • Shares Out37.21M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.58
  • YTD % Change-34.08

RATIOS/PROFITABILITY

  • EPS (TTM)1.40
  • P/E (TTM)1.06
  • Fwd P/E (NTM)-3.80
  • EBITDA (TTM)73.859M
  • ROE (TTM)132.23%
  • Revenue (TTM)135.869M
  • Gross Margin (TTM)99.16%
  • Net Margin (TTM)53.14%
  • Debt To Equity (MRQ)12.84%

EVENTS

  • Earnings Date03/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SCYNEXIS Inc

 

Content From Our Affiliates

Profile

MORE
SCYNEXIS, Inc. is a biotechnology company. The Company is developing its lead product candidate, ibrexafungerp, as a broad-spectrum, intravenous (IV)/oral agent for multiple fungal indications in both the community and hospital settings. Its Ibrexafungerp has demonstrated activity against a large collection of medically relevant strains of Candida and Aspergillus genera, including multidrug-resistant strains, as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces...
Guy Macdonald
Non-Executive Independent Chairman of the Board
David Angulo M.D.
President, Chief Executive Officer, Director
Ivor Macleod CPA
Chief Financial Officer
Scott Sukenick J.D.
General Counsel
Address
1 Evertrust Plaza, 13Th Floor
Jersey City, NJ
07302-6548
United States

Top Peers

SYMBOLLASTCHG%CHG
ACOR
Acorda Therapeutics Inc
12.50+0.59+4.95%
ASRT
Assertio Holdings Inc
0.9522-0.0378-3.8182%
AYTU
Aytu Biopharma Inc
3.12+0.04+1.30%
SCTL
Societal CDMO Inc
1.08-0.01-0.46%
MEIP
MEI Pharma Inc
3.99+0.07+1.79%